Anti-GLCCI1 monoclonal antibody

Pre-made anti-GLCCI1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GLCCI1/GLCCI1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0912-Ab-1/ GM-Tg-hg-IP0912-Ab-2Anti-Human GLCCI1 monoclonal antibodyHuman
GM-Tg-rg-IP0912-Ab-1/ GM-Tg-rg-IP0912-Ab-2Anti-Rat GLCCI1 monoclonal antibodyRat
GM-Tg-mg-IP0912-Ab-1/ GM-Tg-mg-IP0912-Ab-2Anti-Mouse GLCCI1 monoclonal antibodyMouse
GM-Tg-cynog-IP0912-Ab-1/ GM-Tg-cynog-IP0912-Ab-2Anti-Cynomolgus/ Rhesus macaque GLCCI1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0912-Ab-1/ GM-Tg-felg-IP0912-Ab-2Anti-Feline GLCCI1 monoclonal antibodyFeline
GM-Tg-cang-IP0912-Ab-1/ GM-Tg-cang-IP0912-Ab-2Anti-Canine GLCCI1 monoclonal antibodyCanine
GM-Tg-bovg-IP0912-Ab-1/ GM-Tg-bovg-IP0912-Ab-2Anti-Bovine GLCCI1 monoclonal antibodyBovine
GM-Tg-equg-IP0912-Ab-1/ GM-Tg-equg-IP0912-Ab-2Anti-Equine GLCCI1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0912-Ab-1/ GM-Tg-hg-IP0912-Ab-2; GM-Tg-rg-IP0912-Ab-1/ GM-Tg-rg-IP0912-Ab-2;
GM-Tg-mg-IP0912-Ab-1/ GM-Tg-mg-IP0912-Ab-2; GM-Tg-cynog-IP0912-Ab-1/ GM-Tg-cynog-IP0912-Ab-2;
GM-Tg-felg-IP0912-Ab-1/ GM-Tg-felg-IP0912-Ab-2; GM-Tg-cang-IP0912-Ab-1/ GM-Tg-cang-IP0912-Ab-2;
GM-Tg-bovg-IP0912-Ab-1/ GM-Tg-bovg-IP0912-Ab-2; GM-Tg-equg-IP0912-Ab-1/ GM-Tg-equg-IP0912-Ab-2
Products NameAnti-GLCCI1 monoclonal antibody
Formatmab
Target NameGLCCI1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GLCCI1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0912-Ag-1Recombinant multi-species GLCI1/ GLCCI1/ FAM117C protein
    ORF Viral VectorpGMAD000371mouse Glcci1 Adenovirus plasmid
    ORF Viral VectorvGMAD000371mouse Glcci1 Adenovirus particle


    Target information

    Target IDGM-IP0912
    Target NameGLCCI1
    Gene ID113263,170772,296884,696004,612938,101099704,541048,100064230
    Gene Symbol and Synonyms2310047L21Rik,A130036A18Rik,FAM117C,GCTR,GIG18,GLCCI1,RGD1563612,TSSN1
    Uniprot AccessionQ86VQ1
    Uniprot Entry NameGLCI1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000106415
    Target ClassificationN/A

    The target: GLCCI1, gene name: GLCCI1, also named as FAM117C, GCTR, GIG18, TSSN1. This gene encodes a protein of unknown function. Expression of this gene is induced by glucocorticoids and may be an early marker for glucocorticoid-induced apoptosis. Single nucleotide polymorphisms in this gene are associated with a decreased response to inhaled glucocorticoids in asthmatic patients. [provided by RefSeq, Feb 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.